Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [4607]

N-acetyl cysteine improves efficacy of adoptive T cell immunotherapy for melanoma

N-acetyl cysteine improves efficacy of adoptive T cell immunotherapy for melanoma

Long-term experience supports efficacy and safety of PRRT for treating neuroendocrine tumours

Long-term experience supports efficacy and safety of PRRT for treating neuroendocrine tumours

Breast cancer resistance to tamoxifen elucidated

Breast cancer resistance to tamoxifen elucidated

Helicobacter metabolism contributes to gastric cancer through CagA translocation

Helicobacter metabolism contributes to gastric cancer through CagA translocation

A noninvasive approach may identify glioblastoma patients suitable for antiangiogenic therapy

A noninvasive approach may identify glioblastoma patients suitable for antiangiogenic therapy

ESMO 2016: Greater patient selection may be needed for first line nivolumab to improve PFS in advanced lung cancer

ESMO 2016: Greater patient selection may be needed for first line nivolumab to improve PFS in advanced lung cancer

ESMO 2016: Nivolumab maintains function and reduces symptoms in relapsed metastatic head and neck cancer

ESMO 2016: Nivolumab maintains function and reduces symptoms in relapsed metastatic head and neck cancer

‘Game-changing’ immunotherapy doubles head and neck cancer survival

‘Game-changing’ immunotherapy doubles head and neck cancer survival

ESMO 2016: Neoadjuvant immunotherapy prior to surgery is safe and feasible in early lung cancer

ESMO 2016: Neoadjuvant immunotherapy prior to surgery is safe and feasible in early lung cancer

Four PD-L1 assays tested in new comparative study

Four PD-L1 assays tested in new comparative study

More from ecancer